|
|
Article: Recent findings from University of Tubingen highlight research in uveitis.
- Article from:
- Biotech Week
- Article date:
- August 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In this recently published article, scientists in Tubingen, Germany conducted a study "To assess the efficacy and tolerability of interferon (IFN) alpha in chronic cystoid macular oedema (CMO) due to non-infectious uveitis. Retrospective analysis of an interventional case series."
"IFN alpha-2a was administered at an initial dose of 3 or 6 million IU per day subcutaneously and tapered afterwards to the lowest possible dose to maintain the absence of CMO. Treatment efficacy was assessed by optical coherence tomography. Twenty-four patients with chronic CMO (median duration 36.0 months) due to non-infectious anterior (n = 2), intermediate (n = 18) or posterior (n ...
Related newspaper, magazine, and journal articles:
|
|
Tubingen.(Baden Wurttemberg)
Germany Adventure Guide;
January 1, 2005 ;
700+ words
...The lovely small town of Tubingen has a lot in common with Heidelberg. It ... Information is available from the Verkehrsverein Tubingen, Tourist & Ticket Center, An der Neckarbrucke, 72072 Tubingen, [telephone] 07071-91-360, www ...
|
|